Miro Venturi, PhD, MSc
Senior Vice President, Head of Biopharma
Miro Venturi, Ph.D., M.Sc., joined Foundation Medicine as SVP, Head of Biopharma in December 2019. Dr. Venturi brings over 15 years of experience in pharmaceutical R&D and diagnostics, building business strategies for drug discovery and diagnostics product development across therapeutic areas including oncology, infectious diseases, immunology, and rare diseases. Dr. Venturi is passionate about ensuring better access to precision medicine through the development of companion diagnostics, data models, and strong partnerships in the development of new therapeutic options.
Dr. Venturi joined FMI from Roche, where he served as the global head of diagnostics biomarkers and personalized healthcare. He established strategies to further Roche Diagnostics’ work in biomarker development and implemented projects to address areas of unmet medical need and other business opportunities. Dr. Venturi also led the personalized healthcare strategy between Roche Diagnostics and other pharmaceutical divisions within the company.
Prior to joining Roche, Dr. Venturi was the division head of biomarker development at Novartis Pharmaceuticals, where he was responsible for overseeing biomarker and bio-analytical assays development to support research and development efforts. Before that, he served as the head of analytical biology at Nerviano Medical Sciences.
Dr. Venturi holds a Ph.D. in biochemistry from the Max-Planck Institute of Biophysics in Germany and a M.Sc. in biological sciences from the University of Bologna, Italy. He completed his post-doctoral fellowship at the National Institutes of Health.